Summary
The metastasis of cancer to bone is a frequent outcome of common malignancies and is often associated with significant morbidity due to osteolysis. Bone metastasis is also selective in that a disproportionately small number of malignancies account for the majority of tumors which spread to bone. While the mechanisms of bone destruction have been studied, those responsible for the site-specific nature of bone metastasis are poorly understood. As a metastatic target, bone is unique in that it is continuously being remodelled under the influence of local and systemic growth factors, many of which are embedded in the bone matrix. This review summarizes evidence for the hypothesis that the formation of metastatic tumors in bone is the consequence of a unique microenvironment where metastatic cells can alter the metabolism of bone, thereby regulating the release of soluble bone-derived growth factors as a consequence of bone resorption. These, in turn, can modulate the malignant phenotypic properties of receptive cells. Transforming growth factor-β is one factor which can promote the growth and motility of Walker 256 cells, a rat cell line with a propensity to metastasize spontaneously to bone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Nielsen OS, Munro AJ, Tannock IF: Bone metastases: Pathophysiology and management policy. J Clin Oncol 9:509–524, 1991
Hortobagyi GN: Bone metastases in breast cancer patients. Semin Oncol 18:11–15, 1991
Body JJ: Metastatic bone disease: Clinical and therapeutic aspects. Bone 13:S57-S62, 1992
Tubiana-Hulin M: Incidence, prevalence, and distribution of bone metastases. Bone 12:S9-S10, 1991
Paget S: The distribution of secondary growths in cancer of the breast. Lancet i:571–573, 1889
Batson OV: The role of vertebral veins in metastatic processes. Ann Int Med 16:38–46, 1942
Shevrin DH, Gorny KI, Kukreja SC: Patterns of metastasis by the human prostate cancer cell line PC-3 in athymic nude mice. Prostate 15:187–194, 1989
Geldof AA, Rao BR: Factors in prostate cancer metastasis. Anticancer Res 10:1303–1306, 1990
Weiss L: The biomechanics of cancer cell traffic, arrest, and intravascular destruction.In Orr FW, Buchanan MR, Weiss L (eds) Microcirculation in Cancer Metastasis. CRC Press, Boca Raton, 1991, pp 131–144
Shim SS: Physiology of blood circulation of bone. J Bone Joint Surg [Am] 50-A:812–824, 1968
De Bruyn PPH: Structural substrates of bone marrow function. Semin Hematol 18:179–193, 1981
Kamenov B, Longenecker BM: Further evidence for the existence of ‘homing’ receptors on murine leukemia cells which mediate adherence to normal bone marrow stromal cells. Leuk Res 9:1529–1537, 1985
Goldfarb RH, Liotta LA: Proteolytic enzymes in cancer invasion and metastasis. Seminars in Thrombosis and Hemostasis 12:294–307, 1986
Brodt P, Reich R, Moroz LA: Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis. Biochim Biophys Acta 1139: 77–83, 1992
Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. N Engl J Med 324:1–8, 1991
Partin AW, Schoeniger JS, Mohler JL, Coffey DS: Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 86:1254–1258, 1989
Nicolson GL: Organ specificity of tumor metastasis: role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites. Cancer Metastasis Reviews 7:143–188, 1988
Kramer RH, Enenstein J, Ramos DM, Vu MP, Cheng Y-F: The role of integrin receptors in tumor cell adhesion to the microvasculature.In Orr FW, Buchanan MR, Weiss L (eds) Microcirculation in Cancer Metastasis. CRC Press, Boca Raton, 1991, pp 145–167
Scher HI, Yagoda A: Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Am J Med 82:6–28, 1987
Wright JA, Egan SE, Greenberg AH: Genetic regulation of metastatic progression. Anticancer Res 10:1247–1256, 1990
Birchmeier W, Behrens J, Weidner KM, Frixen UH, Schipper J: Dominant and recessive genes involved in tumor cell invasion. Current Opinion in Cell Biology 3:832–840, 1991
Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME: Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 48:6550–6554, 1988
Onoda JM, Piechocki MP, Kantak S, Honn KV: Low dose radiation stimulates tumor cell adhesion and metastasis. FASEB J 6:A1358, 1992
Lafrenie RM, Podor TJ, Buchanan MR, Orr FW: Upregulated biosynthesis and expression of endothelial cell vitronectin receptor enhances cancer cell adhesion. Cancer Res 52:2202–2208, 1992
Elliott BE, Tam S-P, Dexter D, Chen ZQ: Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: Effect of estrogen and progesterone. Int J Cancer 51:416–424, 1992
Radinsky R: Growth factors and their receptors in metastasis. Seminars in Cancer Biology 2:169–177, 1991
Canalis E, McCarthy TL, Centrella M: Growth factors and cytokines in bone cell metabolism. Annu Rev Med 42:17–24, 1991
Agha FP, Norman A, Hirschl S, Klein R: Paget's disease coexistence with metastatic carcinoma. NY State J Med 76:734–735, 1976
Powell N: Metastatic carcinoma in association with Paget's disease of bone. Br J Radiol 56:582–585, 1983
Krempien B: The Walker carcinosarcoma 256 as an experimental model of bone metastases: influence of local and metabolic factors on incidence and pattern of metastases. Calcif Tissue Int 36:S26, 1984
Powles TJ, Clark SA, Easty DM, Neville AM: The inhibition by aspirin and indomethacin of osteolytic tumour desposits and hypercalcemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer 28:316–321, 1973
Guaitani A, Sabatini M, Coccioli G, Cristina S, Garattini S, Bartosek I: An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1-bis(phosphonate). Cancer Res 45:2206–2209, 1985
Garattini S, Guaitani A, Mantovani A: Effect of etidronate disodium on the interactions between malignancy and bone. Am J Med 82:29–33, 1987
Powles TJ, Dowsett M, Easty GC, Easty DM, Neville AM: Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet i:608–610, 1976
Fitton A, McTavish D: Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 41:289–318, 1991
Mohan S, Baylink DJ: Bone growth factors. Clin Orthop Rel Res 263:30–48, 1991
Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB: Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J Cell Biol 105:456–463, 1987
Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsburn M: Growth factors in bone matrix: Isolation of multiple types by affinity chromatography on heparin-sepharose. J Biol Chem 261:12665–12674, 1986
Bautista CM, Mohan S, Baylink DJ: Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. Metabolism 39:96–100, 1990
Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N: Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factors I, II, and transforming growth factor α. Br J Cancer 65:341–346, 1992
Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A: Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. Cancer Res 52:3636–3641, 1992
Gleave M, Hsieh JT, Gao C, von Eschenbach AC, Chung LWK: Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51:3753–5761, 1991
Globus RK, Plouet J, Gospodarowicz D: Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124:1539–1547, 1989
Canalis E, McCarthy TL, Centrella M: Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol 150:530–537, 1989
Tsukamoto T, Matsui T, Nakata H, Ito M, Natazuka T, Fukase M, Fujita T: Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the α-receptor-specific up-regulation. J Biol Chem 266:10143–10147, 1991
Zhang L, Leeman E, Carnes DC, Graves DT: Human osteoblasts synthesize and respond to platelet-derived growth factor. Am J Physiol 261:C348-C354, 1991
Hanazawa S, Ohmori Y, Amano S, Miyoshi T, Kumegawa M, Kitano S: Spontaneous production of interleukin-l-like cytokine from a mouse osteoblastic cell line (MC353-E1). Biochem Biophys Res Commun 131:774–779, 1985
Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T: IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297–3303, 1990
Littlewood AJ, Russell J, Harvey GR, Hughes DE, Russell RGG, Gowen M: The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 129:1513–1520, 1991
Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I: Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 50:7786–7788, 1990
Kerbel R: Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am J Pathol 141:519–524, 1992
Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50:6184–6191, 1990
Herlyn M, Malkowicz SB: Regulatory pathways in tumor growth and invasion. Lab Invest 65:262–271, 1991
Keski-Oja J, Koli K, Lohi J: Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Semin Thromb Hemostasis 17:231–239, 1991
Chackal-Roy M, Niemeyer C, Moore M, Zetter BR: Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 84:43–50, 1989
Gleave ME, Hsieh JT, von Eschenbach AC, Chung LW: Prostate and bone fibroblasts induce human prostate cancer growth in vivo: Implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 147:1151–1159, 1992
Arguello F, Furlanetto RW, Baggs RB, Graves BT, Harwell SE, Cohen HJ, Frantz CN: Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes S1/S1d and W/Wv). Cancer Res 52:2304–2309, 1992
Bataille R, Chappard D, Klein B: Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Amer 6:285–295, 1992
Boyce BF: Normal bone remodelling and its disruption in metastatic bone disease. In Rubens RD, Fogelman I (eds) Bone Metastases: Diagnosis and Treatment. Springer-Verlag, London, 1991, p 11–30
Clarke NW, McClure J, George MJR: Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol 68:74–80, 1991
Mundy GR: Mechanisms of osteolytic bone destruction. Bone 12:S1-S6, 1991
Kelly PJ, Eisman JA: Hypercalcemia of malignancy. Cancer Metastasis Reviews 8:23–52, 1989
Kulenkampff HA, Dreyer T, Kersjes W, Delling G: Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas. Virchows Arch [A] 409:817–828, 1986
Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennet RC, Martin TJ: Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites. Cancer Res 51:3059–3061, 1991
Athanasou NA, Quinn JMW: Human tumour-associated macrophages are capable of bone resorption. Br J Cancer 65:523–526, 1992
Quinn JMW, Athanasou NA: Tumour infiltrating macrophages are capable of bone resorption. J Cell Sci 101:681–686, 1992
Eilon G, Mundy GR: Direct resorption of bone by human breast cancer cells in vitro. Nature 276: 726–728, 1978
Galasko CSB: Bone metastases studies in experimental animals. Clin Orthoped Rel Res 155:269–285, 1981
Bassani D, Sabatini M, Scanziani E, De Francesco L, Coccioli G, Guaitani A, Bartosek I: Bone invasion by Walker 256 carcinoma, line A, in young and adult rats: effects of etidronate. Oncology 47:160–165, 1990
Arguello F, Baggs RB, Eskenazi AE, Duerst RE, Frantz CN: Vascular anatomy and organ-specific tumor growth as critical factors in the development of metastases and their distribution among organs. Int J Cancer 48:583–590, 1991
Geldof AA, Rao BR: Factors in prostate cancer metastasis. Anticancer Res 10:1303–1306, 1990
Geldof AA, Rao BR: Prostatic tumor (R3327) skeletal metastasis. Prostate 16:279–290, 1990
Simpkins H, Lehman JM, Mazurkiewicz JE, Davis BH: A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 51:1334–1338, 1991
Kostenuik PJ, Singh G, Suyama KL, Orr FW: A quantitative model for spontaneous bone metastasis: Evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metastasis 10:403–410, 1992
Tam CS, Heersche JNM, Santora A, Speigel AM: Skeletal response in rats following the implantation of hypercalcemia-producing leydig cell tumors. Metabolism 33:50–53, 1984
Insogna KL, Weir EC, Wu TL, Stewart AF, Broadus AE, Burtis WJ, Centrella M: Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy. Endocrinology 120:2183–2185, 1987
Kostenuik PJ, Singh G, Suyama KL, Orr FW: Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone. Clin Exp Metastasis 10:411–418, 1992
Raisz LG, Niemann I: Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 85:446–452, 1969
Ozaki T, Yoshida K, Ushijima K, Hayashi H: Studies on the mechanisms of invasion in cancer: II. In vivo effects of a factor chemotactic for cancer cells. Int J Cancer 7:93–100, 1971
Orr FW, Lam W-C, Delikatny EJ, Mokashi S, Varani J: Localization of intravenously injected tumor cells in the rat mesentery after intraperitoneal administration of chemotactic stimuli. Invasion Metastasis 1:239–247, 1981
Orr W, Varani J, Gondek MD, Ward PA, Mundy GR: Chemotactic responses of tumor cells to products of resorbing bone. Science 203:176–179, 1979
Orr FW, Varani J, Gondek MD, Ward PA, Mundy GR: Partial characterization of a bone-derived chemotactic factor for tumor cells. Am J Pathol 99:43–52, 1980
Oda D, Orr FW: Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis. Invasion Metastasis 4:189–197, 1984
Magro C, Orr FW, Manishen WJ, Sivananthan K, Mokashi S: Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone. JNCI 74:829–838, 1985
Kleinman HK, Klebe RJ, Martin GR: Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 88:473–485, 1981
Wass JA, Varani J, Piontek GE, Ward PA, Orr FW: Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide. Cell Differ 10:329–332, 1981
Mundy GR, DeMartino S, Rowe DW: Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 68:1102–1105, 1981
Malone JD, Teitelbaum SL, Griffin GL, Senior RM, Kahn AJ: Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92:227–230, 1982
Mundy GR, Poser JW: Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif Tissue Int 35:164–168, 1983
Centrella M, Canalis E: Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. Proc Natl Acad Sci USA 82:7335–7339, 1985
Centrella M, McMarthy TL, Canalis E: Skeletal tissue and transforming growth factor beta. FASEB J 2:3066–3073, 1988
Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 165:251–256, 1987
Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ: Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157:793–800, 1988
Orr FW, Millar-Book W, Singh G: Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat Walker 256 carcinosarcoma cells. Invasion Metastasis 10:241–252, 1990
Manishen WJ, Sivananthan K, Orr FW: Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis. Am J Pathol 123:39–45, 1986
Schwarz LC, Gingras MC, Goldberg G, Greenberg AH, Wright JA: Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res 48:6999–7003, 1988
Millar-Book W, Orr FW, Singh G: In vitro effects of bone and platelet-derived transforming growth factor-β on the growth of walker 256 carcinosarcoma cells. Clin Exp Metastasis 8:503–510, 1990
Cote RJ, Rosen PP, Old LJ, Osborne MP: Detection of bone marrow micrometastases in patients with early-stage breast cancer. Diagn Oncol 1:37–42, 1991
Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer 27:1552–1555, 1991
Mansi JL, Berger UTA, Easton D, McDonnell T, Redding WH, Gazet J-C, McKinna A, Powles TJ, Coombes RC: Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295:1093–1096, 1987
Ellis G, Ferguson M, Yamanaka E: Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer 63: 2509–2514, 1989
Stahel RA, Mabry M, Skarin AT, Speak J, Bernal SD: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3:455–461, 1985
Bezwoda WR, Lewis D, Livini N: Bone marrow involvement in anaplastic small cell lung cancer. Diagnosis, hematologic features, and prognostic implications. Cancer 58:1762–1765, 1986
Skov BG, Hirsch FR, Bobrow L: Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer. Br J Cancer 65:593–596, 1992
Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller G: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immuno-cytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8:831–837, 1990
Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, Riethmuller G: Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance. Eur J Cancer 27:1461–1465, 1991
Author information
Authors and Affiliations
Additional information
Supported by an educational grant from CIBA-GEIGY Corp., at the San Antonio Breast Cancer Symposium, Dec. 8, 1992.
Rights and permissions
About this article
Cite this article
Orr, F.W., Kostenuik, P., Sanchez-Sweatman, O.H. et al. Mechanisms involved in the metastasis of cancer to bone. Breast Cancer Res Tr 25, 151–163 (1993). https://doi.org/10.1007/BF00662140
Issue Date:
DOI: https://doi.org/10.1007/BF00662140